Tiblio
Sign Up

ARAY

Accuray Incorporated
NASDAQHEALTHCAREMEDICAL DEVICES

Key Statistics

Market Cap
$18.60M
P/E Ratio
—
EPS
$-0.40
Beta
1.42
52W High
$1.79
52W Low
$0.15
50-Day MA
$0.26
200-Day MA
$0.41
Dividend Yield
—
Profit Margin
-12.20%
Forward P/E
94.34
PEG Ratio
29.49

About Accuray Incorporated

Accuray Incorporated designs, develops and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body in the Americas, Europe, the Middle East, India, Japan, Africa and the rest of the Asia Pacific region. The company is headquartered in Sunnyvale, California.

Official WebsiteUSAFY End: June

Fundamentals

Revenue (TTM)$401.95M
Gross Profit (TTM)$111.45M
EBITDA$-3.53M
Operating Margin6.21%
Return on Equity-80.10%
Return on Assets-1.40%
Revenue/Share (TTM)$3.28
Book Value$0.35
Price-to-Book0.65
Price-to-Sales (TTM)0.05
EV/Revenue0.423
EV/EBITDA15.07
Quarterly Earnings Growth (YoY)-96.20%
Quarterly Revenue Growth (YoY)-20.90%
Shares Outstanding$119.44M
Float$113.61M
% Insiders4.24%
% Institutions64.66%

Historical Volatility

HV 10-Day
101.74%
HV 20-Day
158.38%
HV 30-Day
131.32%
HV 60-Day
121.45%
HV Rank
—

Volatility is currently contracting

Latest News

Accuray Announces Stockholder Approval of Key Financing-Related Proposals and Appointment of New Independent Director

MADISON, Wis., Oct. 6, 2026 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) today announced that stockholders approved all proposals presented at the company's Special Meeting of Stockholders held on October 6, 2026, enabling Accuray to complete its previously announced transactions with TCW Asset Management Company LLC, the company's primary lender and largest shareholder.

PRNewsWire10/6/2026Neutral
Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities

MADISON, Wis., Sept. 11, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems for cancer treatment, and RaySearch Laboratories AB (publ) today announced that they had entered into a definitive agreement providing for an expanded collaboration aimed at accelerating Accuray's adoption of online adaptive radiation therapy.

PRNewsWire9/11/2026Neutral
Accuray Advances Strategic Priorities Through Key Executive Leadership Appointments

MADISON, Wis., Aug. 12, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced two key leadership appointments intended to improve operational execution and profitability, deliver increased customer value, and enhance overall enterprise performance as the company continues to advance the strategic priorities in its recently announced transformation plan focused on sustainable, profitable growth.

PRNewsWire8/12/2026Neutral
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules

MADISON, Wis., May 29, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Paul Miele, the company's new Chief Commercial Officer and David Shin, the company's new Chief Legal Officer.

PRNewsWire5/29/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ARAY and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

LLYEli Lilly and CompanyJNJJohnson & JohnsonABBVAbbVie IncUNHUnitedHealth Group IncorporatedMRKMerck & Company IncNVSNovartis AG ADRAZNAstraZeneca PLCTMOThermo Fisher Scientific IncAMGNAmgen IncGILDGilead Sciences IncABTAbbott LaboratoriesNVONovo Nordisk A/S
View all HEALTHCARE stocks →
Data last updated: 10/17/2026